Showing results (971-980 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|November 4, 2016
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell CarcinomaRobert J Motzer, Bernard Escudier, Andrew Gannon, et al.The Oncologist|November 4, 2016
Targeting the KRAS Pathway in Non-Small Cell Lung CancerPascale Tomasini, Preet Walia, Catherine Labbe, et al.The Oncologist|April 24, 2014
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation studyKatherine M Krajewski, Yoko Franchetti, Mizuki Nishino, et al.The Oncologist|February 20, 2019
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint InhibitorsNethanel Asher, Edith M Marom, Guy Ben-Betzalel, et al.The Oncologist|February 21, 2019
Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic CommunicationMasanori Mori, Maiko Fujimori, Hiroto Ishiki, et al.The Oncologist|April 1, 2017
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed GlioblastomaMarco Skardelly, Elena Dangel, Julia Gohde, et al.The Oncologist|March 6, 2019
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening EraTira Tan, Michael Rheaume, Lisa Wang, et al.The Oncologist|March 6, 2019
Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and PreventabilityAmanda Hanora Lavan, Deirdre O'Mahony, Mary Buckley, et al.The Oncologist|March 6, 2019
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced CancerAiwu Ruth He, Roger B Cohen, Crystal S Denlinger, et al.The Oncologist|November 18, 2018
Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.SSarah N Price, Jamie L Studts, Heidi A HamannPageof 570